Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants (Q24247492)

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Intravenous immunoglobulin for prophylaxis of neonatal sepsis in premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

The use of intravenously administered immunoglobulins in the prevention of severe infection in very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Effect of fresh frozen plasma and gammaglobulin on humoral immunity in neonatal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

New uses of intravenous immune globulin in newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Use of intravenously administered immune globulin in newborn infants: prophylaxis, treatment, both, or neither?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Immunoglobulin therapy for neonatal sepsis: an overview of animal and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Immune globulin to prevent nosocomial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Intravenous immune globulin doses and infection prophylaxis in very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Treatment of sepsis with IgG in very low birthweight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Neonatal sepsis: pathogenesis and supportive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

Intravenous immunoglobulin for prophylaxis of nosocomial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Intravenously administered immune globulin for premature infants: a time to wait

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: report of a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Dosage of intravenously administered immune globulin and dosing interval required to maintain target levels of immunoglobulin G in low birth weight infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Therapeutic uses of intravenous gammaglobulin for pediatric infections.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Standard versus hyperimmune intravenous immunoglobulin in preventing or treating neonatal bacterial infections.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Rational principles for immunoglobulin prophylaxis and therapy of neonatal infections.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Serum gamma-G-globulin levels and gestational age in premature babies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Immunotherapy and immunoprophylaxis in the newborn infant: the need for definitive clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Intravenous gammaglobulin in the prophylaxis of late sepsis in very-low-birth-weight infants: preliminary results of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Role of intravenous immunoglobulin in prevention of late-onset infection in low-birth-weight neonates. The Neonatal IVIG Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Polyvalent group B streptococcal immune globulin for intravenous administration: overview

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Intravenous immunoglobulin in the treatment of neonatal sepsis: therapeutic strategies and laboratory studies.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Intravenous immunoglobulin for prevention of sepsis in preterm and low birth weight infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Opsonic activity of commercially available standard intravenous immunoglobulin preparations.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Neonatal Uses of Intravenous Immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Prophylactic intravenous immunoglobulin in pre-term infants: a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021

Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000361.PUB2

7 January 2021